![Sapan Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sapan Shah currently works at Glyscend, Inc., as Chief Executive Officer & Director from 2023.
Dr. Shah also formerly worked at Rycarma Therapeutics, Inc., as Chief Executive Officer, Shionogi, Inc., as Chief Executive Officer, and StrideBio, Inc., as Chief Executive Officer.
Dr. Shah received his undergraduate degree from Northwestern University and doctorate degree from Yale University.
| Unternehmen | Position | Beginn |
|---|---|---|
Glyscend, Inc.
 Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Develops oral metabolic therapeutics for the treatment of type 2 diabetes | Vorstandsvorsitzender | 05.09.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
Shionogi, Inc.
 Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Vorstandsvorsitzender | - |
Rycarma Therapeutics, Inc.
 Rycarma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small-molecule therapeutics | Vorstandsvorsitzender | - |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 6 |
|---|---|
Rycarma Therapeutics, Inc.
Rycarma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small-molecule therapeutics | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Health Technology |
Glyscend, Inc.
Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Develops oral metabolic therapeutics for the treatment of type 2 diabetes | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
